An analysis of factor influencing the outcome of patients with locally advanced larynx cancer;Analiza czynników rokowniczych u chorych z miejscowo zaawansowanym rakiem krtani

Otolaryngologia Polska

Volumn 62, Issue 6, 2008, Pages 691-694

  Kubrak, Jadwiga ^a   Jarema, Alina ^a   Falco, Michał ^b   Rogowska, Danuta ^a   Rubik, Agnieszka ^a   Torbé, Bogdan ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b Zachodniopomorskie Centrum Onkologii   (Poland)

Author keywords

Adjuvant radiotherapy; Larynx cancer; Risk factors; Time factor

Indexed keywords

EID: 58149279086     PISSN: 00306657     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0030-6657(08)70341-x     Document Type: Article

References (19)

1. Amdur R, Parsons J, Mendenhall W i wsp. Postoperative irradiation for squamous cell carcinoma of head and neck: an analysis of treatment results and complications. Int J Rad Oncol Biol Phys 1989; 16: 25-36.
2. Amdur RJ, Parson JT, Mendenhall WM i wsp. Split-course versus continous-course irradiation in the postoperative setting for squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1989; 17: 279-285.
3. Sas-Korczyńska B. Analiza przyczyn niepowodzenia leczenia chorych na raka krtani po całkowitym wycieciu krtani i pooperacyjnej radioterapii. Nowotwory 1998; 48: 643-62.
4. Ang KK, Trotti A, Brown BW i wsp. Randomized trial adressing risk features and time factors of surgery plus radiotherapy in advanced head and neck cancer. Int J Radiat Oncol Biol Phys 2001; 51: 571-578.
5. Allen ER A trial of radiation dose prescription based on dose - cell survival formula. Radiol 1984; 28: 156-160.
6. Daly T, Poulsen MG, Denham JW i wsp. The effect of anaemia on efficacy and normal tissue toxicity following radiotherapy for locally advanced squamous cell carcinoma of head and neck. Radiother Oncol 2003; 68: 113-22.
7. Guttenberger R, Lutterbach J, Roth A i wsp. Hemoglobin levels predict loco-regional control after postoperative radiotherapy for advanced head and neck cancer. Eur J Cancer 1997; 33: 102-103.
8. Lee WR, Berkey B, Marcial. V i wsp. Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27. Int J Radiat Oncol Biol Phys 1998; 5: 1069-1075.
9. Lutterbach J, Guttenberger R. Anemia is associated with decreased local control of surgically treated squamous cell carcinomas of the glottic larynx. Int J Radiat Oncol Biol Phys 2000; 48: 1345-1350.
10. Naude J, Dobrowski W. Anemia as predictor of locoregional control in radiotherapy of laryngeal cancer Radiother Oncol 1996; 40: 96.
11. Overgaard J, Hansen HS, Jorgensen K i wsp. Primary radiotherapy of larynx and pharynx carcinoma. An analysis of some factors influencing local control and survival. Int J Radiat Biol Phys 1986; 12: 515-521.
12. Overgaard J, Hansen HS, Overgaard M i wsp. A randomized double-blind phase III study of nimorazol as a hypoxic radio sesitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. Radiother Oncol 1998; 48: 344-346.
13. Overgaard J, Hansen HS, Overgaard M i wsp. Conventional radiotherapy as primary preatment of squamous cell carcinoma of the head and neck. A randomized multicenter study of 5 versus 6 fractions per week-report from the Dahanca 7 trial. Int J Radiat Oncol Biol Phys 1997; 39: 188.
14. Marcus RB, Million R, Cassissi NJ: Postoperative irradiation for squarnous cell carcinomas of head and neck: analysis of time-dose factors related to control above the clavicles. Int J Rad Oncol Biol Phys 1997; 5: 1943-1949.
15. Peters LJ: The efficacy of postoperative radiotherapy for advanced head and neck cancer: Quality of the evidence. Int J Radiat Oncol Biol Phys 1998; 40: 527-528.
16. Peters LJ, Goepfert H, Ang KK. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. Int J Radiat Oncol Biol Phys 1993; 26: 3-11.
17. Pinto LHJ, Canary PCV, Araujo CMM i wsp. Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stage III and IV oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1991; 21: 557-562.
18. Glanz HK: Carcinoma of the larynx. Adv Otorhinolaryngol 1984; 32: 1-123.
19. Solano J, Esteban F, Delgado M i wsp. Histopathological malignancy and prognosis of laryngeal cancer. Acta Otorrinolaringol Esp 1997; 48: 375-382.